Difference between revisions of "Stub"
m (→MTP) |
|||
| Line 384: | Line 384: | ||
====Immunotherapy==== | ====Immunotherapy==== | ||
*[[Pembrolizumab (Keytruda)]] | *[[Pembrolizumab (Keytruda)]] | ||
| + | |||
| + | ==PGV== | ||
| + | {| class="wikitable" style="float:right; margin-left: 5px;" | ||
| + | |- | ||
| + | |[[#top|back to top]] | ||
| + | |} | ||
| + | PGV: '''<u>P</u>'''latinol (Cisplatin), '''<u>G</u>'''emcitabine, '''<u>V</u>'''inorelbine | ||
| + | ===Regimen=== | ||
| + | ====Chemotherapy==== | ||
| + | *[[Cisplatin (Platinol)]] | ||
| + | *[[Gemcitabine (Gemzar)]] | ||
| + | *[[Vinorelbine (Navelbine)]] | ||
==Pixantrone & Rituximab== | ==Pixantrone & Rituximab== | ||
Revision as of 17:53, 7 September 2020
Regimens that have not proven to be superior to a standard-of-care comparison and are thus unlikely to be expanded upon unless new evidence comes forward. This page is primarily to drive the Ontology.
Abiraterone & Enzalutamide
| back to top |
Regimen
Hormonotherapy
ACP
| back to top |
ACP: Atezolizumab, Carboplatin, Paclitaxel
Regimen
Immunotherapy
Chemotherapy
Afatinib & Vinorelbine
| back to top |
Regimen
Chemotherapy
Targeted therapy
Bortezomib & Bevacizumab
| back to top |
Regimen
Targeted therapy
Bortezomib & Siltuximab
| back to top |
Regimen
Targeted therapy
BTH (Taxotere)
| back to top |
BTH: Bevacizumab, Taxotere (Docetaxel), Herceptin (Trastuzumab)
Regimen
Chemotherapy
Targeted therapy
CAD
| back to top |
CAD: Cyclophosphamide, Adriamycin (Doxorubicin), DDP (Cisplatin)
Regimen
Chemotherapy
Carboplatin & Epirubicin
| back to top |
Regimen
Chemotherapy
Carboplatin & Topotecan
| back to top |
Regimen
Chemotherapy
CE & Ipilimumab
| back to top |
CE & Ipilimumab: Carboplatin, Etoposide, Ipilimumab
Regimen
Chemotherapy
Immunotherapy
CE & Thalidomide
| back to top |
CE & Thalidomide: Carboplatin, Etoposide, Thalidomide
Regimen
Chemotherapy
Targeted therapy
Cisplatin & Methotrexate
| back to top |
Regimen
Chemotherapy
Cisplatin, Pemetrexed, RT
| back to top |
Regimen
Chemotherapy
Radiotherapy
- Concurrent radiation therapy
CP & Bexarotene
| back to top |
CP & Bexarotene: Carboplatin, Paclitaxel, Bexarotene
Regimen
Chemotherapy
CP & Cediranib
| back to top |
CP & Cediranib: Carboplatin, Paclitaxel, Cediranib
Regimen
Chemotherapy
Targeted therapy
CP & Cetuximab
| back to top |
CP & Cetuximab: Carboplatin, Paclitaxel, Cetuximab
Regimen
Chemotherapy
Targeted therapy
CP & Erlotinib
| back to top |
CP & Erlotinib: Carboplatin, Paclitaxel, Erlotinib
Regimen
Chemotherapy
Targeted therapy
CP & Sorafenib
| back to top |
CP & Sorafenib: Carboplatin, Paclitaxel, Sorafenib
Regimen
Chemotherapy
Targeted therapy
CP & Veliparib
| back to top |
CP & Velaparib: Carboplatin, Paclitaxel, Velaparib
Regimen
Chemotherapy
Targeted therapy
Docetaxel & Pertuzumab
| back to top |
Regimen
Chemotherapy
Targeted therapy
Encorafenib monotherapy
| back to top |
Regimen
Targeted therapy
EP & Ipilimumab
| back to top |
EP & Ipilimumab: Etoposide, Platinol (Cisplatin), Ipilimumab
Regimen
Chemotherapy
Immunotherapy
EP, Tamoxifen, RT
| back to top |
EP, GM-CSF, RT: Etoposide, Platinol (Cisplatin), Tamoxifen, Radiation Therapy
Regimen
Chemotherapy
Hormonotherapy
Radiotherapy
- Concurrent thoracic radiation therapy
FAP
| back to top |
FAP: Fluorouracil, Alfa interferon, Platinol (Cisplatin)
Regimen
Chemotherapy
Immunotherapy
FEC & HP
| back to top |
FEC & HP: Fluorouracil, Epirubicin, Cyclophosphamide, Herceptin (Trastuzumab), Pertuzumab
Regimen
Chemotherapy
Targeted therapy
FULV & Trimetrexate
| back to top |
FULV & Trimetrexate: 5-FU & LeucoVorin (Folinic acid), Trimetrexate
Regimen
Chemotherapy
Ixabepilone & Bevacizumab
| back to top |
Regimen
Chemotherapy
Targeted therapy
MFL
| back to top |
MFL: Methyl-lomustine (MeCCNU), 5-FU & LeucoVorin (Folinic acid)
Regimen
Chemotherapy
Mitoxantrone & Hydrocortisone
| back to top |
Regimen
Chemotherapy
Hormonotherapy
MTP
| back to top |
MTP: Myocet (Non-pegylated liposomal doxorubicin), Trastuzumab, Paclitaxel
Regimen
Chemotherapy
Targeted therapy
NIP
| back to top |
NIP: Navelbine (Vinorelbine), Ifosfamide, Platinol (Cisplatin)
Regimen
Chemotherapy
PD & Pembrolizumab
| back to top |
PD & Pembrolizumab: Pomalidomide, Dexamethasone, Pembrolizumab
Regimen
Targeted therapy
Immunotherapy
PGV
| back to top |
PGV: Platinol (Cisplatin), Gemcitabine, Vinorelbine
Regimen
Chemotherapy
Pixantrone & Rituximab
| back to top |
Regimen
Chemotherapy
Targeted therapy
TCHL (Taxotere)
| back to top |
TCHL: Taxotere (Docetaxel), Carboplatin, Herceptin (Trastuzumab), Lapatinib
Regimen
Chemotherapy
Targeted therapy
TCL (Taxotere)
| back to top |
TCL: Taxotere (Docetaxel), Carboplatin, Lapatinib
Regimen
Chemotherapy
Targeted therapy
TEC
| back to top |
TEC: Taxol (Paclitaxel), Epirubicin, Carboplatin
Regimen
Chemotherapy
TG+Bev
| back to top |
TG+Bev: Taxotere (Docetaxel), Gemcitabine, Bevacizumab
Regimen
Chemotherapy
Targeted therapy
TH (Taxol) & Everolimus
| back to top |
TH & Everolimus: Taxol (Paclitaxel), Herceptin (Trastuzumab), Everolimus
Regimen
Chemotherapy
Targeted therapy
TL (Taxotere)
| back to top |
TL: Taxotere (Docetaxel) & Lapatinib
Regimen
Chemotherapy
Targeted therapy
TX+Bev
| back to top |
TX+Bev: Taxotere (Docetaxel), Xeloda (Capecitabine), Bevacizumab
Regimen
Chemotherapy
Targeted therapy
Vinorelbine & Hydrocortisone
| back to top |
Regimen
Chemotherapy
Hormonotherapy
VTDC
| back to top |
VTDC: Velcade (Bortezomib), Thalidomide, Dexamethasone, Cyclophosphamide